153 related articles for article (PubMed ID: 14564205)
1. Genetic screening in haemolytic uraemic syndrome.
Zipfel PF; Neumann HP; Józsi M
Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):653-7. PubMed ID: 14564205
[TBL] [Abstract][Full Text] [Related]
2. Atypical haemolytic uraemic syndrome.
Kavanagh D; Goodship TH; Richards A
Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
[TBL] [Abstract][Full Text] [Related]
3. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
Dragon-Durey MA; Frémeaux-Bacchi V
Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
5. Familial haemolytic uraemic syndrome and an MCP mutation.
Noris M; Brioschi S; Caprioli J; Todeschini M; Bresin E; Porrati F; Gamba S; Remuzzi G;
Lancet; 2003 Nov; 362(9395):1542-7. PubMed ID: 14615110
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells.
Heinen S; Józsi M; Hartmann A; Noris M; Remuzzi G; Skerka C; Zipfel PF
J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916
[TBL] [Abstract][Full Text] [Related]
7. The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
Richards A; Goodship JA; Goodship TH
Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):431-5. PubMed ID: 12105394
[TBL] [Abstract][Full Text] [Related]
8. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.
Caprioli J; Castelletti F; Bucchioni S; Bettinaglio P; Bresin E; Pianetti G; Gamba S; Brioschi S; Daina E; Remuzzi G; Noris M;
Hum Mol Genet; 2003 Dec; 12(24):3385-95. PubMed ID: 14583443
[TBL] [Abstract][Full Text] [Related]
9. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.
Manuelian T; Hellwage J; Meri S; Caprioli J; Noris M; Heinen S; Jozsi M; Neumann HP; Remuzzi G; Zipfel PF
J Clin Invest; 2003 Apr; 111(8):1181-90. PubMed ID: 12697737
[TBL] [Abstract][Full Text] [Related]
10. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
12. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
14. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
[TBL] [Abstract][Full Text] [Related]
15. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
Verhave JC; Wetzels JF; van de Kar NC
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv131-41. PubMed ID: 25165180
[TBL] [Abstract][Full Text] [Related]
16. Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP).
Benz K; Amann K
Thromb Haemost; 2009 Feb; 101(2):265-70. PubMed ID: 19190808
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.
Neumann HP; Salzmann M; Bohnert-Iwan B; Mannuelian T; Skerka C; Lenk D; Bender BU; Cybulla M; Riegler P; Königsrainer A; Neyer U; Bock A; Widmer U; Male DA; Franke G; Zipfel PF
J Med Genet; 2003 Sep; 40(9):676-81. PubMed ID: 12960213
[TBL] [Abstract][Full Text] [Related]
18. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
19. The molecular biology of thrombotic microangiopathy.
Tsai HM
Kidney Int; 2006 Jul; 70(1):16-23. PubMed ID: 16760911
[TBL] [Abstract][Full Text] [Related]
20. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
